about
Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.Ligands for ionotropic glutamate receptorsImmunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity.A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus.Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat.Dihydrokainate-sensitive neuronal glutamate transport is required for protection of rat cortical neurons in culture against synaptically released glutamate.
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Pharmacologic properties of NMDA receptors.
@ast
Pharmacologic properties of NMDA receptors.
@en
type
label
Pharmacologic properties of NMDA receptors.
@ast
Pharmacologic properties of NMDA receptors.
@en
prefLabel
Pharmacologic properties of NMDA receptors.
@ast
Pharmacologic properties of NMDA receptors.
@en
P2093
P2860
P1476
Pharmacologic properties of NMDA receptors.
@en
P2093
Benveniste M
Patneau DK
Vyklicky L Jr
P2860
P304
P356
10.1111/J.1749-6632.1992.TB24538.X
P407
P577
1992-05-01T00:00:00Z